0.000542647131370005 0.000542647131370005 0.0012826204923289 0.000641310246164449 -0.00922500123328896 -0.00651176557643921 -0.00315721967342516 -0.0066104286912338
Sign Up Today X
Thanks for submitting the form.
Stockreport

Is It Too Late To Consider Incyte After A 45% Rally In 2025? [Yahoo! Finance]

Incyte Corporation (INCY)  More Company Research Source: Yahoo! Finance
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
This is exactly the question we are going to unpack. The stock is up 44.8% year to date and 44.2% over the last year, even after a modest 1.3% pullback over the past month following a 2.1% rise in the most recent week. This suggests that the market is rapidly rethinking its growth and risk profile. That shift has been driven by a stream of positive pipeline and regulatory updates, alongside growing investor focus on its key dermatology and oncology franchises. Together, these factors have reinforced the narrative that Incyte is evolving from a single product story into a more diversified biopharma platform, which can justify a different valuation lens. On our checks, Incyte scores 5 out of 6 for valuation, suggesting it screens as undervalued on most, but not all, of the metrics we use. Next we will walk through those different valuation approaches in detail, then finish by looking at a more holistic way to judge whether the current price really reflects the long term opportunit [Read more]
IMPACT SNAPSHOT EVENT TIME: INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
INCY alerts
from News Quantified
INCY
NEWS
INCY
Earnings
INCY
Analyst Actions
INCY
SEC Filings
Stockreport

Is It Too Late To Consider Incyte After A 45% Rally In 2025? [Yahoo! Finance]

Incyte Corporation  (INCY) 
More Company Research Source: Yahoo! Finance
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
This is exactly the question we are going to unpack. The stock is up 44.8% year to date and 44.2% over the last year, even after a modest 1.3% pullback over the past month following a 2.1% rise in the most recent week. This suggests that the market is rapidly rethinking its growth and risk profile. That shift has been driven by a stream of positive pipeline and regulatory updates, alongside growing investor focus on its key dermatology and oncology franchises. Together, these factors have reinforced the narrative that Incyte is evolving from a single product story into a more diversified biopharma platform, which can justify a different valuation lens. On our checks, Incyte scores 5 out of 6 for valuation, suggesting it screens as undervalued on most, but not all, of the metrics we use. Next we will walk through those different valuation approaches in detail, then finish by looking at a more holistic way to judge whether the current price really reflects the long term opportunit [Read more]
IMPACT SNAPSHOT
EVENT TIME:
INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS